Literature DB >> 4604053

Absorption and clearance of secobarbital, heptabarbital, methaqualone, and ethinamate.

J M Clifford, J H Cookson, P E Wickham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4604053     DOI： 10.1002/cpt1974162376

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

Review 2.  Clinical pharmacokinetics of hypnotics.

Authors:  D D Breimer
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

3.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

4.  Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man.

Authors:  D D Breimer; A G de Boer
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

5.  Long-term urinary excretion of methaqualone in a human subject.

Authors:  H D Heck; K Maloney; M Anbar
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

6.  Comparison of the residual effects of two benzodiazepines (nitrazepam and flurazepam hydrochloride) and pentobarbitone sodium on human performance.

Authors:  R G Borland; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

7.  Behavioural sequelae of methaqualone in man and in the monkey (Macaca mulatta).

Authors:  R G Borland; A N Nicholson; C M Wright
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.